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ABSTRACT 
 
Background 
Neurolisteriosis ranks among the most severe neurological infections. Its radiological features have not 
been thoroughly studied. We aimed to describe the neuroradiological features of neurolisteriosis and 
assess their prognostic value. 
 
Methods 
Patients with microbiologically-proven neurolisteriosis were enrolled from November 2009 to October 
2013 in the nationwide MONALISA study. Magnetic resonance and computed tomography images were 
studied by two independent neuroradiologists. Predictors of 3-month mortality were determined using 
logistic regression. 
 
Results 
Seventy-one patients were included; 42 were men (59%). Mean age was 64 years. Sixty patients (85%) 
reported signs of encephalitis, with clinical brainstem involvement in 16 (23%). Images were abnormal 
in 87% of cases (62/71). Main neuroradiological images were meningeal enhancement (25/71, 35%), 
abscess(es) or nodular image(s) evocative of abscess (10/71, 14%), haemorrhages (11/71, 15%), 
contrast-enhancing ventricles or hydrocephalus (7/71, 10%). White-matter images (42/71, 59%), dilated 
Virchow-Robin spaces (22/71, 31%) and cerebral atrophy were also reported (34/71, 48%). Brainstem 
involvement (meningeal enhancement, abscess) was reported in only 7/71 cases (10%). Three-month 
survival was lower in patients with hydrocephalus or contrast-enhancing ventricles (1/7 (14%) than 
without (47/64, 73%), p=0.005) and in patients with parenchymal images (abscess(es), nodule(s) or 
white matter images) (25/46 (54%) versus 23/25 without (92%), p=0.004). Parenchymal images were 
associated with lower 3-month survival in the multivariable model (odds ratio 5.60, 95% CI [1.42-29.6], 
p= 0.02). 
 
Conclusions 
Neurolisteriosis presents as a combination of neuroradiological images, none being specific. 
Radiological signs of rhombencephalitis are uncommon, whereas, unexpectedly, hemorrhagic images 
are frequent. The negative prognostic value of parenchymal neuroradiological images was evidenced. 
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INTRODUCTION 
 Listeria monocytogenes (Lm) is a foodborne pathogen responsible for listeriosis, a severe 
systemic infection affecting pregnant women, immuno-suppressed individuals and the elderly. Three 
main clinical forms are described: maternal-neonatal infections, septicaemia and neurolisteriosis. 
Neurolisteriosis typically presents as a meningoencephalitis (evidenced in 84% of cases) or less 
commonly as a meningitis without encephalitis (13% of cases)	[1-3]. In some Western countries, Lm is 
one of the leading etiological agents of meningo-encephalitis in adults, together with Herpes simplex 
virus, Varicella zoster virus and Mycobacterium tuberculosis [4] [5]; and is associated with the highest 
morbi-mortality, despite appropriate antimicrobial therapy. Three-months mortality is around 30%, with 
persisting neurological impairment reported in 44% of surviving patients [3]. Most neurolisteriosis cases 
are therefore managed in intensive care management (60%), with 33% requiring mechanical ventilation 
[3]. The radiological presentation of neurolisteriosis remains poorly characterized and only reported as 
scattered observations focusing on brain abscesses or rhombencephalitis [6-8] [9]. Yet, careful 
evaluation of central nervous system imaging in patients with neurolisteriosis is critical for a better 
understanding of the pathophysiology of this deadly infection, and to help refine clinical care. 
MONALISA is a national prospective cohort study of invasive listeriosis implemented in France 
since 2009, compiling all cases of invasive listeriosis reported through national mandatory reporting, 
whose exhaustiveness was recently estimated around 87% [10]. For all included cases, a large dataset 
of clinical features and clinical isolates were collected [3]. The clinical results of this study were recently 
published, and new prognostic factors for neurolisteriosis were evidenced: concomitant positive blood 
cultures, the use of adjunctive dexamethasone or mechanical ventilation requirement were 
independently associated with higher 3-month mortality; encephalitis signs and the number of 
neurological symptoms were also associated with a higher-risk of persisting neurological impairment 
[3]. Radiological data have not been analyzed in this clinical study. No correlation between radiological 
and clinical data has ever been reported, and the impact of radiological abnormal images has not been 
studied to our knowledge. We took advantage of this collection of neuroradiological imaging data of 
patients with neurolisteriosis to characterize the radiological features of neurolisteriosis and determine 
their prognostic value. 
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METHODS 
Study population – Neurolisteriosis cases were microbiologically confirmed and defined as follow: 
isolation of Listeria monocytogenes from the cerebrospinal fluid (CSF) or brain abscess, isolation of 
Listeria monocytogenes from blood cultures in patients with otherwise unexplained neurological 
symptoms (altered consciousness, seizures, nuchal rigidity, or focal neurological symptoms), isolation 
of Listeria monocytogenes from blood cultures and in CSF by qPCR. They were included from Nov 
2009 to Oct 2013 from the MONALISA national prospective observational cohort study, whose design 
has been reported [3].  
All patients or their legal representatives when unable to consent provided written informed consent. In 
accordance with French legislation, the study received institutional review board approval by the local 
ethics committee (Comité de Protection des Personnes Ile De France III, Nov-6 2009). Clinical and 
biological data were available at baseline and at 3-month follow-up. Radiological files were collected 
from clinicians. The study is registered at Clinical Trials (NCT01520597). 
 
Radiological evaluation – As cases were scattered all over France, neuroimaging was performed 
according to local hospital practices. Brain computed tomography (CT) and magnetic resonance (MR) 
images performed from baseline were sent by the clinicians along with clinical data. They analyzed by 
two neuroradiologists highly experienced in neuroimaging of infections. Images were analyzed 
according to a pre-established checklist. There was no abnormal image evidenced that was not listed in 
the checklist. Two independent analyses were performed; in case of discrepancy, a third was performed 
with both radiologists to reach consensus. 
 
Definitions 
- Meningeal enhancement was defined after injection of gadolinium chelates on T1-weighted images on 
MR or after injection of iodine contrast medium on helicoidal CT scan. Meningeal enhancement was 
classified as leptomeningeal (involvement of pia mater or subarachnoid spaces) or pachymeningeal 
(involvement of dura mater). 
- Brain abscesses were defined as nodules or masses with peripheral enhancement after injection after 
injection of gadolinium chelates on T1-weighted images on MR, or of iodine contrast media on 
helicoidal CT scan. When available, hyper intensity on MR diffusion weighting images was also taken 
into account to confirm the diagnosis of brain abscess. 
- Nodules evocative of abscess were defined as enhanced nodules after injection of contrast media, but 
lacking typical peripheral enhancement.  
- Diffuse cerebral edema was defined as diffuse hyper intense signal of the cerebral white matter with 
effacement of the sulci on T2-weighted or Flair MRI sequences or as diffuse cerebral white matter 
hypodensity with effacement of the sulci on helicoidal CT scan. 
	 5	
- Non-specific white matter images were defined as non-specific hyper intense signal of the white matter 
on T2-weighted MRI sequences or as non-specific white matter hypodensities on helicoidal CT scan. 
- Cerebral atrophy was defined on both MRI and CT scan as a parenchymal volume loss with enlarged 
cerebral sulci (cortical atrophy) and/or ventriculomegaly without bulging of the third ventricular 
recesses (central atrophy). 
- Dilated Virchow Robin spaces were defined as linear fluid signal non-enhancing spaces located in the 
basal ganglia or midbrain. 
- Cerebral herniation was defined as a shift of cerebral tissue from its normal location into an adjacent 
space. 
- Contrast-enhancing ventricles were defined as ventricles with enhancement of the ependymal lining 
after injection of gadolinium chelates on T1-weighted images on MRI or after injection of iodine 
contrast media on helicoidal CT scan. 
- Hydrocephalus was defined as an enlargement of the ventricles without cerebral atrophy. 
- Radiological vasculitis was defined as enhanced cortical grey matter after injection of gadolinium 
chelates on T1-weighted images on MRI or after injection of iodine contrast media on helicoidal CT 
scan, possibly associated with hemorrhages or ischemic lesions. 
- Hemorrhage was defined as a lesion with hyper intense signal on T1-weighted sequences or marked 
low signal on GRET2* weighted sequences on MRI, or as a spontaneously hyper dense lesion (not 
calcified) on helicoidal CT scan. 
- Ischemic images were defined as focal lesions of the cortical or subcortical matter with increased 
diffusion weight imaging (DWI) signal and reduced apparent diffusion coefficient (ADC) values on 
MRI or hypodensity after injection of iodine contrast media on helicoidal CT scan. 
- Clinical encephalitis was defined by the presence of at least one of the following symptoms, with no 
alternative cause than listeriosis identified: altered consciousness (score on Glasgow Coma Scale (GCS) 
<15), seizures, new onset of neurological symptoms and abnormality on electroencephalography [3, 11]. 
 
Statistical analysis – The sample size was a convenient sample, determined by the number of available 
images during the study period. All tests were performed with R software (version 3.4.0). All tests were 
2-tailed and p-values <0.05 (calculated by Chi2 test, Fisher exact test or Student’s t test) were considered 
significant. For the multivariable analysis of mortality, candidate variables were the variables showing 
association at a significance level of p < 0.10 in the univariable analysis; the three clinical variables 
previously shown associated most strongly associated with mortality in neurolisteriosis were included 
in the multivariable model, and a stepwise selection was done [3]. Inter-rater agreement has been 
quantified by Cohen’s kappa statistics. Disagreement was considered if one radiologist described one 
lesion as present when the other one described it as absent or not interpretable. The situation where one 
radiologist answered that a lesion was absent when the other one described it as uninterpretable was not 
considered as a disagreement. Confidence intervals were computed using the bootstrap method, i.e., 
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numerical resampling. Agreement was not computed for following signs owing to their low prevalence 
(< 3%, i.e. less than 3 patients, for at least one of the radiologists): brain herniation, brain edema, 
radiological vasculitis and ventricular involvement.	Observer agreement was categorized by kappa 
values as poor (<0.39), moderate (0.40-0.59), good (0.60-0.79) or excellent (>0.80)	[12]. 
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RESULTS 
Characteristics of the study population – The patients’ characteristics are described in Table 1. Fifty 
nine percent were men (42/71). Sixty patients (85%) reported encephalitis signs including clinical 
brainstem symptoms in 23 percent (16/71). Patients with neuroimaging available were similar to those 
of the French neurolisteriosis cohort in terms of age, gender, number and frequency of comorbidities, 
GCS, rate of encephalitis and focal signs, cerebrospinal fluid features, proportion of isolates with 
virulent clonal complexes, death and persisting impairment rates (p >0.1, data not shown) [3]. 
 
Neuroradiological presentation at baseline – The first radiological procedure was performed after a 
median time interval of 2 days from the time of the diagnosis procedure (blood or cerebrospinal fluid 
sample) (interquartile range 0-11 days). The neuroradiological features are detailed in Table 2. 
Altogether, abnormal neuroradiological findings were found in 62 of the 71 patients (83%). Meningeal 
enhancement was reported in 25/71 (35%). It consisted in pachy- or lepto-meningeal enhancement, focal 
(n=2) or diffuse (n=23). Twelve patients had meningeal enhancement evidenced before lumbar puncture 
was performed, excluding the possibility of non-specific dural and/or arachnoid enhancement, which 
can be observed after lumbar puncture [13]. 
Abscesses and/or nodular images evocative of abscesses (see Methods) were reported in 10/71 cases 
(14%). They were unique or multiple (1 to six, median number of 2), with diameter ranging from 7 to 
18 mm. They were infra-tentorial (brainstem) in 5/10 cases (50%), supra-tentorial in 4/10 cases (40%) 
and both supra- and infra-tentorial in one case (1/10, 10%). 
Hemorrhages were reported in an unexpected high proportion of cases (11/71, 15%). They involved 
parenchyma in all cases and were classified as supratentorial in 7 cases, subtentorial in 1, and both 
supratentorial and subtentorial in 3 cases. They consisted in petechial images (7/11) or hematoma (4/11). 
Parenchymal hemorrhages could also be associated with subarachnoid hemorrhage (n=2) or ventricular 
hemorrhage (n=1). In 7/11 cases concomitant predisposing conditions were evidenced: hypertension 
(n=3), pre-existing tumoral (n=2) or vascular (n=1) lesions, anticoagulation and thrombocytopenia (< 
20,000/mm3) (n=1, each). 
Importantly, major ventricular involvement (contrast-enhancing ventricles or hydrocephalus) were 
evidenced in 7 cases (7/71, 10%). Non-specific deep white-matter images were also frequently reported 
(42/71, 59%). In all but 2 cases, they could be attributed to age (> 50 years, n=39), and/or concomitant 
hypertension (n=20), or HIV infection (n=1). 
All combinations of radiological signs were observed (data not shown). Altogether, brainstem 
involvement with meningeal enhancement or abscess(es) was reported in only 7/71 cases (10%). No 
involvement of choroid plexuses was found. MRI detected more meningeal enhancement, dilated 
Virchow Robin spaces and hydrocephalus than CT scan (p< 0.05, Table 2). 
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Correlation with clinical and microbiological features – Clinical and radiological data were 
compared (Figure S1). No correlation between radiological presentation and the number of 
immunosuppressive comorbidities was found, except for vascular images (ischemia or hemorrhage) that 
were more frequently reported in patients reporting above 2 immunosuppressing comorbidities (12/19) 
that in others (8/46, p=0.0002). All patients radiologically diagnosed with hemorrhages, ventricles 
involvement (contrast-enhancement or hydrocephalus), cerebral herniation, cerebral edema or vasculitis 
also had clinical signs of encephalitis involvement as defined above. However, there was no correlation 
between clinical signs and neuroradiological findings. Indeed, only 4/7 (57%) patients with radiological 
evidence of brainstem involvement exhibited brainstem symptoms (namely cranial nerve involvement) 
at the time of evaluation. Furthermore, 12/16 (75%) of patients exhibiting clinical brainstem signs did 
not have brainstem neuroradiological lesions on MRI (n=10) or CT scan (n=2) (Figure S1A). Similarly, 
6/25 (24%) patients with meningeal enhancement did not report nuchal rigidity (Figure S1B), although 
all of them (25/25) had alterations of the cerebrospinal fluid (defined as cerebrospinal fluid nucleated 
cells count >4/mm3 and/or CSF protein >0.5g/L and/or evidence of viable L. monocytogenes in the 
cerebrospinal fluid). A patient with brain abscess/nodule did not report clinical signs of encephalitis 
(1/10). Finally, no correlation was evidenced between isolate genotype (either hyper or hypovirulent, as 
reported  in Maury et al [14]) and radiological presentation (data not shown). 
 
Relationship between baseline brain images and outcome – Patients with neurolisteriosis and 
ventricle involvement (hydrocephalus or contrast-enhancement) and those with parenchymal images 
(abscess(es), nodule(s) and/ or non-specific white matter images) evidenced significantly lower 3-month 
survival in the univariate analysis (respectively, 1/7 (14%) in patients with ventricle involvement versus 
47/64 (73%, p=0.005) in those without and 25/46 (54%) in patients with parenchymal images versus 
23/25 (92%) in those without, p=0.004) (Table S1). Parenchymal lesions (abscess(es), nodule(s) and/ 
or non-specific white matter lesions) remained associated with poor 3-month survival for patients in the 
multivariable model (Table 3). No link between radiological pattern and long-term impairment was 
evidenced (data not shown). 
 
Radiological evolution – Of the 71 patients, 9 had another neuroimaging procedure performed after at 
least a 1-week interval, including 6 with the same type of imaging (MRI or CT scan). Images were found 
stable in 4 cases (including one patient with 18 mm abscesses reevaluated after 10 days, one patient with 
parenchymal hematoma reevaluated after 5 weeks and one patient with persisting meningeal 
enhancement reevaluated after 9 months), or improved in one case with brain hematoma (reevaluation 
after 4 and 6 weeks). One single case developed focal parietal meningitis after 7 days in the context of 
altered consciousness despite appropriate therapy, he died 1 week later as a consequence of severe 
neurolisteriosis. 
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Radiological lectures concordance tests – Inter-rater agreement was strong for all lesions, with 
Cohen’s kappa index all ranging from good (hydrocephalus, dilated Virchow Robin spaces, atrophy, 
non-specific white matter lesion, ischemic images) to excellent (meningeal enhancement, nodular lesion 
evocative of abscess, abscess(es) and hemorrhages) (Table S2). 
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DISCUSSION 
The French mandatory reporting made it possible for the first time to collect a large set of 
radiological files from patients with neurolisteriosis, and to analyze them together with a large dataset 
of clinical data [3]. Only culture-proven cases were included. To our knowledge, previous studies have 
only been focused on specific images like abscesses or rhombencephalitis, while other signs were only 
reported as scattered observations [9, 14]. This systematic evaluation of neuroradiological features 
allowed an unbiased description of the neuroradiological features of neurolisteriosis. We could thereby 
determine that abnormal images were observed in 83% of cases, corresponding to meningeal 
enhancement, abscess(es) and nodular images (s) evocative of abscess, hemorrhages, ventricular 
involvement (contrast-enhancing ventricles or hydrocephalus), non-specific white matter images and 
dilated Virchow–Robin spaces, and rarely to diffuse cerebral edema and cerebral herniation. 
Abscesses, meningeal enhancement, hydrocephalus, ischemia and brain edema have been 
reported before as scattered observations [15-19]; however, a systematic analysis of radiological files 
allowed us to determine the relative frequency of each radiological sign, and to point out the rarity of 
brain abscesses and of brainstem involvement; although they were the cardinal features reported in the 
neurolisteriosis literature so far [20-22]. Typical abscesses have indeed been reported in numerous case 
reports, as highlighted by the retrospective work by Cone and coll., who compiled 40 cases of Listeria-
related brain abscesses published from 1966 to 2003 [14]; they were however evidenced in only 6% of 
our case series after systematic evaluation, suggesting a bias in previous publications. Similarly, the 
brainstem radiological involvement called “rhombencephalitis” which is usually considered very 
suggestive of neurolisteriosis [23][9] was only reported in 10% of cases; this low sensitivity mirrors 
clinical data, as brainstem involvement is only reported in 17% of cases [3]. For the first time, we 
evidenced the unexpected frequency of hemorrhages and ventricular involvement, that, to our 
knowledge, had been reported only in scattered observations so far [17, 24]. Haemorrhages could occur 
as a consequence of  associated conditions in 64% of cases; they could also reflect  a Listeria endothelial 
tropism, although Listeria monocytogenes might invade a large array of host cells, including endothelial 
cells, either directly or via infected monocytes [25, 26]. The pathophysiological mechanisms underlying 
ventricular involvement (contrast-enhancement and/or hydrocephalus) remain to be determined, 
especially whether this reflects an invasion site form infected CSF, or an extension from parenchymal 
infection [27]. 
Altogether, these results highlight the non-specific neuroradiological presentation of 
neurolisteriosis, which is not associated with any pathognomonic radiological sign nor any specific 
combination of signs, and can affect any brain compartment (parenchyma, blood vessels, meninges and 
ventricles). Clinicians should be aware that the absence of radiological rhombencephalitis, brain abscess 
or meningeal-enhancement does not rule out neurolisteriosis and should not be taken into account for 
empiric anti-Listeria therapy when neurolisteriosis is considered. Diagnosis is indeed often delayed until 
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the results of blood and cerebrospinal fluid cultures or qPCR, as clinical signs are nonspecific and direct 
examination of the cerebrospinal fluid evidences Gram positive rods in only 32% of cases [3]. 
Some neuroradiological features were associated with poorer 3-month survival in 
neurolisteriosis in univariate analysis: ventricular involvement with hydrocephalus or contrast-
enhancing ventricles and parenchymal imaging combining abscess(es), and/or nodule(s) and/or white 
matter images; and multivariable analysis (parenchymal images defined above). Although we cannot 
exclude overfitting of the logistic model, because of the limited sample size, these images  should be 
added to the other parameters shown associated with poor outcome, namely ongoing cancer, female 
gender, recent major weight loss, multi-organ failure, aggravation of any pre-existing organ dysfunction, 
mechanical ventilation, monocytopenia, positive blood culture and adjunctive dexamethasone therapy 
[3, 28]. Neuroimaging is recommended in encephalitis as a part of the diagnosis procedure [29]. It should 
be performed for all patients with confirmed neurolisteriosis, as part of the global assessment of patient’s 
severity. Furthermore, some lesions might require specific management, like ischemic and hemorrhagic 
signs, and hydrocephalus or cerebral herniation requiring neurosurgical management. Because all 
patients with such abnormal images do not all exhibit matching clinical symptoms, neuroimaging should 
also be performed the 14% of patients with neurolisteriosis who do not exhibit clinical signs of 
encephalitis. In line with other neurological infections, MRI should be preferred to CT scan, as it 
displays a greater sensitivity (Table 2) [23, 30, 31]. 
The high inter-rater agreement underlines the reliability of radiological evaluation and 
strengthen this recommendation. However, our study has limitations. First, we did not set any 
harmonized neuroimaging protocol in the setting of this observational study, and the dataset reflected 
these heterogeneous local practices. Also, the sample size hampered further statistical analyses. We 
could not collect radiological files for all patients included in the MONALISA cohort, and selection bias 
could not be ruled out, although the study cohort appeared representative of the global picture of 
neurolisteriosis in France, without evidence for any distinctive clinical feature or increased severity.  
 
CONCLUSIONS 
In conclusion, this study shows that neurolisteriosis presents as a combination of neuroradiological 
images, none of them being specific. Signs of rhombencephalitis are uncommon, whereas, 
unexpectedly, hemorrhagic signs are frequent. This study identified parenchymal neuroradiological 
images associated with a negative prognostic value that will help improve the management of this severe 
infection. 
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FIGURE LEGENDS 
 
 
Figure 1. Main patterns of radiological neurolisteriosis in magnetic resonance imaging (MRI) 
procedures. A. Axial contrast-enhancing T1-weighted MRI with a ring-like enhancing pons image 
corresponding to an abscess (arrow head). B. Axial contrast-enhancing T1-weighted MRI with a ring-
enhancing image of the right parietal lobe corresponding to an abscess (arrow head) with diffuse 
meningeal enhancement. C. Axial T2 gradient-echo MRI with markedly hypo signal in right cerebellar 
peduncle corresponding to focal bleeding. D. Axial diffusion weighted MRI with bilateral supra-
tentorial cerebral dot-like hyper signals corresponding to ischemic images highly evocating of 
radiological vasculitis. E. Axial T2 spin-echo MRI with symmetric hyper signals of supra-tentorial white 
matter. F. Axial contrast-enhancing T1-weighted MRI with hydrocephalus and ventricular ependymal 
lining enhancement. 
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Table 1. Characteristics of 71 patients with neurolisteriosis and brain imaging available 
 
Characteristics  Patients with neuroimaging N=71 
Epidemiological features  
Median age – years (no· evaluated) 64±18 (71) 
Male gender – no·/ no· evaluated (%)  42/71 (59)  
Geographical origin (no· evaluated) (71) 
   France – no·/ no· evaluated (%) 57/71 (80) 
   Other European country – no·/ no· evaluated (%) 4/71(6) 
   North America 4/71(6) 
   Africa 3/71 (4) 
   Other areas 3/71 (4) 
Past history  
Mean number of associated comorbidities per patient (no· evaluated) 3±2 (71) 
Immunosuppressive comorbidities  
   Median number of immunosuppressive comorbidities * 2±2 
   Administration of any immunosuppressive therapy in the past 5 years 
   (including corticosteroids) 
23/71 (32) 
(16/71 (23)) 
   Solid organ cancer ✝ 10/71 (14) 
   Hematological malignancy ‡ 7/71 (10) 
   Diabetes mellitus 10/71 (14) 
   Inflammatory bowel disease  5/71 (7) 
   Other auto-immune disease § 4/71 (6) 
   HIV infection 2/71 (3) 
Non- immunosuppressive comorbidities  
   Hypertension 29/71 (41) 
   Chronic respiratory disease 9/71 (13) 
   Renal insufficiency 5/71 (7) 
   Other condition ¶  5/71 (7) 
Age below forty, no identified comorbidity 6/71 (8) 
Clinical features   
Fever 70/71 (99) 
Nuchal rigidity 48/71 (67) 
Encephalitis 60/71 (85) 
Seizures 15/71 (21) 
Mean Glasgow Coma Scale score, no. <8 (coma) / no· evaluated (%) 12±3, 9/71 (13) 
Aphasia 15/71 (21) 
Limb motor deficiency 14/71 (20) 
Limb sensory loss 4/71 (6) 
Any brainstem symptom 16/71 (23) 
   3rd nerve 5/71 (7) 
   5th nerve 1/71 (1) 
   6th nerve 4/71 (6) 
   7th nerve 5/71 (7) 
   8th nerve 4/71 (6) 
Cerebellar syndrome 3/71 (4) 
Extrapyramidal syndrome 3/71 (4) 
Biological features  
Cerebrospinal fluid abnormality, including white-cell count > 10 cells /mm3 69/69 (100), 67/69 (97) 
Cerebrospinal fluid culture positive 63/69 (91) 
Cerebrospinal fluid nucleated cells number median [IQ**25-IQ75] 470 [182-1,028] 
Cerebrospinal fluid protein level (g/L) median [IQ**25-IQ75] 2.0 [1.3-2.9] 
Cerebrospinal fluid glucose level (g/L) median [IQ**25-IQ75] 0.5g/L [0,3-0,7] 
Blood culture positive 38/71 (54) 
Lymphopenia <1500 /mm3 – no· / no· evaluated (%) 56/71 (79) 
Monocytopenia <200 /mm3 – no· / no· evaluated (%) 10/71 (14) 
Clonal complexes  
   Hypervirulent clones (CC1, 2, 4 or 6) 43/71 (61) 
   Hypovirulent clones (CC9 or 121) 2/71 (3) 
   Other clones (others) 26/71 (37) 
Outcome  
   3-month mortality 23/71 (32) 
   Persisting impairment 21/48 (44) 
 
* Immunosuppressive comorbidities included: daily alcohol uptake >3 drinks/day, cirrhosis, diabetes mellitus, end-stage renal disease, solid 
organ cancer, hematological malignancy, hematopoietic stem cell transplantation, solid organ transplantation, asplenia, preexisting 
neutropenia, preexisting lymphopenia, HIV infection, inflammatory bowel disease, inflammatory rheumatic disorder, other auto-immune 
disease, congenital immune deficiency, age >70 years, prescription of corticosteroids or other immunosuppressive therapy in the past 5 years. 
✝ They were hepatocarcinoma, breast or prostate cancers (n=2, each), skin, ethmoidal, brain and lung cancers (n=1, each). Of them, 4/10 (40%) 
were considered as cured.  
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‡ They were chronic lymphoid leukemia (n=5), chronic myeloid leukemia and Waldenstrom’s macroglobulinemia (n=1, each).  
§ They were rheumatoid arthritis and giant cell arteritis (n=2, each).  
¶ They were seizures and chronic liver diseases (n= 2, each). 
**IQ stands for Interquartile 
 
 
 
Table 2. Neuroradiological features of 71 patients with neurolisteriosis and neuroimaging 
 
Neuroradiological finding 
Lesions  
Number of patients  
with radiological lesions* 
 
N=71 
Number of patients 
with lesions on MR*  
N=46 
Number of patients 
with lesions on CT*  
N=30 
p value 
CT vs MR 
Meninges     
   Lepto and/or pachy-meningeal 
enhancement 
25/71 (35) 20/46 (43) 6/30 (20) p=0.048 0.048 
Parenchyma     
   Brain abscess ✝ 
   Nodule evocative of abscess ✝ 
4/71 (6) 
7//71 (10) 
3/46 (7) 
7/46 (15) 
1/30 (3) 
1/30 (3) 
NS 
NS 
   Non-specific white matter lesion 42/71 (59) 30/46 (65) 14/30 (47) NS 
   Atrophy‡ 34/71 (48) 24/46 (52) 12/30 (40) NS 
   Dilated Virchow-Robin spaces 22/71 (31) 20/46 (43) 6/30 (20) 0.048 
   Cerebral herniation§ 2/71 (2) 2/46 (4) 1/30 (3) NS 
   Diffuse cerebral edema 1/71 (1) 1/46 (2) - NS 
Ventricles     
   Contrast-enhancing ventricles 2/71 (3) 2/46 (4) 1/30 (3) NS 
   Hydrocephalus 6/71 (9) 1/46 (2) 6/30 (20) 0.01 
Brain vessels     
   Radiological vasculitis¶ 3/71 (5) 3/46 (7) 1/30 (3) NS 
   Hemorrhage 11/71 (15) 10/46 (22) 1/30 (3) 0.04 
   Ischemia** 8/71 (11) 8/46 (17) 1/30 (3) NS 
Concomitant tumor image ✝✝ 5/71 (7) 4/46 (8) 2/30 (6) NS 
Normal  9/71 (13) 2/46 (4) 7/30 (23) 0.02 
 
* Data presented are those from exam 1 and 2. When one patient had benefited from 2 exams with the same procedure (computed 
tomography of magnetic resonance), data from the first exam were retained for analysis. Patients could have images evidenced 
in both procedures therefore total numbers are not the sum of MRI plus CT scan numbers. 
✝ Brain abscesses and nodules were localized in the frontal lobe, temporal lobe (n=1, each), thalami (n=2), cerebellum (n=1), 
brainstem (n=4), or brainstem and occipital lobe (n=1). 
‡ Atrophy was classified as diffuse in 27/33 (82%) (cortical in 6, subcortical in 7 and both cortical and subcortical in 14) and 
as focal in 6/33 (18%). 
§ Cerebral herniation was classified as uncal or subfalcine (n=1, each). 
¶ Radiological vasculitis was defined as enhanced cortical grey matter after injection of gadolinium chelates on T1-weighted 
images on MR or after infection of iodine contrast media on helicoidal CT scan, possibly associated with haemorrhages or 
ischemic lesions.  
** Ischemic images were considered as sequellar lesions in 3/8 cases, and recent in 5/8. In the 5 images reflecting recent 
lesions, they could be related to the radiological vasculitis in 2/5 cases, altogether they were subtentorial in 3/5 and 
supratentorial in 2/5 cases. 
✝✝ Tumor images included meningioma (n=2) and histologically-confirmed malignant brain tumor (n=3). 
 
 
 
Table 3. Independent predictors for mortality in 71 adults with neurolisteriosis in multivariate analysis. 
 
 
Parameter Odds ratio (95% CI)  p value 
Parenchymal involvement with abscess(es), nodule(s) and/or non-specific white matter images 5.60 (1.42-29.6) 0.02 
Hydrocephalus or contrast-enhancing ventricles 5.96 (0.73-130.17) 0.14 
Positive blood cultures 3.59 (1.06-13.78) 0.04 
Ongoing organ neoplasia 5.03 (0.67-51.5) 0.12 
Adjunctive dexamethasone for meningitis 1.64 (0.24-9.38) 0.58 
 
Odds ratio calculated from the multivariate model. 95% CI: 95% confidence interval. 
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